Breaking News Instant updates and real-time market news.

KDMN

Kadmon

$3.56

-0.155 (-4.18%)

20:59
11/13/19
11/13
20:59
11/13/19
20:59

Kadmon 26M share Spot Secondary priced at $3.40

The deal priced below the last closing price of $3.56. Jefferies and Cantor Fitzgerald are acting as joint book running managers for the offering.

  • 14

    Nov

KDMN Kadmon
$3.56

-0.155 (-4.18%)

06/26/19
06/26/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Slack Technologies (WORK) initiated with an Outperform at Baird. 2. Virtu Financial (VIRT) initiated with a Buy at Rosenblatt. 3. Kadmon (KDMN) initiated with an Outperform at Oppenheimer. 4. Baxter (BAX) initiated with a Sector Weight at KeyBanc. 5. LiveRamp (RAMP) initiated with a Positive at Susquehanna. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/05/19
CANT
09/05/19
INITIATION
Target $8
CANT
Overweight
Kadmon initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald initiated Kadmon with an Overweight and $8 price target.
09/06/19
CANT
09/06/19
INITIATION
Target $8
CANT
Overweight
Cantor starts 'under-the-radar' Kadmon with Overweight rating
Cantor Fitzgerald analyst Eliana Merle last night initiated coverage of Kadmon with an Overweight rating and $8 price target. The company's "under-the-radar asset," KD025, could surprise to the upside both clinically and commercially in chronic graft versus host disease, Merle tells investors in a research note. The analyst thinks KD025 will be successful in its pivotal study in chronic GVHD and that the market is "much larger market than appreciated." She estimates U.S. peak sales of $500M, versus Kadmon's current market capitalization of around $300M. Further, the comapny has several additional clinical programs underway with multiple proof-of-concept readouts in the next 12-18 months, "adding additional optionality," says Merle.
11/12/19
CANT
11/12/19
NO CHANGE
Target $10
CANT
Overweight
Kadmon price target raised to $10 from $8 at Cantor Fitzgerald
Cantor Fitzgerald analyst Eliana Merle raised her price target for Kadmon Holdings to $10 from $8 and reiterates an Overweight rating on the shares. Interim data from KD025 in the chronic graft-versus-host disease pivotal study well exceeded the statistical bar needed for filing, Merle tells investors in a research note. She thinks this is a "robust data update on both efficacy and safety," and supportive of U.S. approval and a meaningful commercial opportunity.

TODAY'S FREE FLY STORIES

ISTR

Investar Holding

$25.55

0.73 (2.94%)

07:51
12/09/19
12/09
07:51
12/09/19
07:51
Downgrade
Investar Holding rating change  »

Investar Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBK

FB Financial

$39.58

0.86 (2.22%)

07:50
12/09/19
12/09
07:50
12/09/19
07:50
Downgrade
FB Financial rating change  »

FB Financial downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$353.99

8.295 (2.40%)

07:49
12/09/19
12/09
07:49
12/09/19
07:49
Recommendations
Boeing analyst commentary  »

Boeing price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$233.74

0.3 (0.13%)

, BGNE

BeiGene

$186.89

-2.3 (-1.22%)

07:47
12/09/19
12/09
07:47
12/09/19
07:47
Recommendations
Amgen, BeiGene analyst commentary  »

Amgen price target raised…

AMGN

Amgen

$233.74

0.3 (0.13%)

BGNE

BeiGene

$186.89

-2.3 (-1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 27

    Feb

AMTD

TD Ameritrade

$51.12

0.32 (0.63%)

, SCHW

Charles Schwab

$48.95

0.22 (0.45%)

07:45
12/09/19
12/09
07:45
12/09/19
07:45
Downgrade
TD Ameritrade, Charles Schwab rating change  »

TD Ameritrade shares…

AMTD

TD Ameritrade

$51.12

0.32 (0.63%)

SCHW

Charles Schwab

$48.95

0.22 (0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFF

International Flavors

$142.03

0.21 (0.15%)

, DD

DuPont

$63.60

1.6 (2.58%)

07:45
12/09/19
12/09
07:45
12/09/19
07:45
Recommendations
International Flavors, DuPont analyst commentary  »

International Flavors…

IFF

International Flavors

$142.03

0.21 (0.15%)

DD

DuPont

$63.60

1.6 (2.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBIO

Mustang Bio

$3.86

0.025 (0.65%)

07:44
12/09/19
12/09
07:44
12/09/19
07:44
Hot Stocks
Mustang Bio: Lentiviral gene therapy with busulfan conditioning 'well tolerated' »

Mustang Bio announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUE

Bluebird Bio

$79.51

-1.24 (-1.54%)

07:44
12/09/19
12/09
07:44
12/09/19
07:44
Recommendations
Bluebird Bio analyst commentary  »

Bluebird Bio price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

AM

Antero Midstream

$4.49

-0.025 (-0.55%)

, AR

Antero Resources

$2.18

0.09 (4.31%)

07:43
12/09/19
12/09
07:43
12/09/19
07:43
Hot Stocks
Antero Midstream to purchase $100M of shares from Antero Resources »

Antero Midstream (AM)…

AM

Antero Midstream

$4.49

-0.025 (-0.55%)

AR

Antero Resources

$2.18

0.09 (4.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCN

FTI Consulting

$111.68

0.28 (0.25%)

07:42
12/09/19
12/09
07:42
12/09/19
07:42
Hot Stocks
FTI Consulting enters partnership with Brainspace »

FTI Consulting announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBIO

BridgeBio

$33.03

0.8 (2.48%)

07:41
12/09/19
12/09
07:41
12/09/19
07:41
Hot Stocks
BridgeBio appoints Eli Wallace as chief scientific officer for oncology »

BridgeBio Pharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOGL

Alphabet Class A

$1,339.41

11.6 (0.87%)

07:40
12/09/19
12/09
07:40
12/09/19
07:40
Recommendations
Alphabet Class A analyst commentary  »

Alphabet shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:40
12/09/19
12/09
07:40
12/09/19
07:40
General news
Treasury Market Outlook: equities have dipped lower in quiet trade »

Treasury Market Outlook:…

EPD

Enterprise Products

$26.25

0.18 (0.69%)

, ENB

Enbridge

$38.52

0.015 (0.04%)

07:39
12/09/19
12/09
07:39
12/09/19
07:39
Hot Stocks
Enterprise Products, Enbridge sign LOI to jointly develop deepwater terminal »

Enterprise Products…

EPD

Enterprise Products

$26.25

0.18 (0.69%)

ENB

Enbridge

$38.52

0.015 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

BLK

BlackRock

$495.78

5.6 (1.14%)

07:39
12/09/19
12/09
07:39
12/09/19
07:39
Conference/Events
BlackRock management to meet with Oppenheimer »

Dinner Meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

  • 26

    Feb

HBIO

Harvard Bioscience

$2.95

0.01 (0.34%)

07:38
12/09/19
12/09
07:38
12/09/19
07:38
Downgrade
Harvard Bioscience rating change  »

Harvard Bioscience…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SESN

Sesen Bio

$1.19

-0.01 (-0.84%)

07:37
12/09/19
12/09
07:37
12/09/19
07:37
Hot Stocks
Sesen Bio initiates rolling submission of BLA for Vicinium to FDA »

Sesen Bio announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BC

Brunswick

$59.81

0.89 (1.51%)

07:36
12/09/19
12/09
07:36
12/09/19
07:36
Conference/Events
Brunswick management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

SSKN

Strata Skin Sciences

$2.16

(0.00%)

07:36
12/09/19
12/09
07:36
12/09/19
07:36
Initiation
Strata Skin Sciences initiated  »

Strata Skin Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Dec

AUB

Atlantic Union Bankshares

$37.82

0.45 (1.20%)

07:35
12/09/19
12/09
07:35
12/09/19
07:35
Conference/Events
Atlantic Union Bankshares management to meet with Compass Point »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

ENB

Enbridge

$38.52

0.015 (0.04%)

, EPD

Enterprise Products

$26.25

0.18 (0.69%)

07:35
12/09/19
12/09
07:35
12/09/19
07:35
Hot Stocks
Enbridge, Enterprise Products to jointly develop crude oil export terminal »

Enbridge (ENB) and…

ENB

Enbridge

$38.52

0.015 (0.04%)

EPD

Enterprise Products

$26.25

0.18 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

07:35
12/09/19
12/09
07:35
12/09/19
07:35
General news
FX Update: The dollar lost ground to the yen and pound »

FX Update: The dollar…

TGTX

TG Therapeutics

$7.11

-0.57 (-7.42%)

07:34
12/09/19
12/09
07:34
12/09/19
07:34
Recommendations
TG Therapeutics analyst commentary  »

TG Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

AMPY

Amplify Energy

$5.39

0.14 (2.67%)

07:33
12/09/19
12/09
07:33
12/09/19
07:33
Conference/Events
Amplify Energy management to meet with Northland »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

ETNB

89bio

$28.38

0.86 (3.13%)

07:33
12/09/19
12/09
07:33
12/09/19
07:33
Initiation
89bio initiated  »

89bio initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.